NF2 = gene Merlin = protein…a.k.a. schwannomin Tumor Suppressor Tumor suppressive ability comes from partial inhibition of Ras/Rac signaling (phosphorylates.

Slides:



Advertisements
Similar presentations
Early Embryonic Development Maternal effect gene products set the stage by controlling the expression of the first embryonic genes. 1. Transcription factors.
Advertisements

Cancer: a genetic disease of inherited and somatic mutations n Gene mutations and/or genetic instability are involved in many cancers. n Viruses and environmental.
NF2/Merlin and Neurofibromatosis 2
What is Li-Fraumeni syndrome?
TSC2 and Tuberous Sclerosis Complex Disease Laura Koontz Biology 169.
Presented by: Jacqueline Holt March 4th 2003
Peutz-Jeghers Syndrome: LBK1/STK11 By Matt Wheeler.
NF2: A Tumor Suppressor NF2 encodes Merlin/Schwannomin, a protein that regulates cell growth and proliferation.
ZAFIA ANKLESARIA Role of BMPR1A in Juvenile Polyposis Syndrome Biology 169.
SMAD4/DPC4: A Tumor Suppressor James Brooks March 23 rd, 2006.
Theories of cancer genesis
Phosphatase and Tensin Homolog Deleted on Chromosome 10
BioSci 145A lecture 18 page 1 © copyright Bruce Blumberg All rights reserved BioSci 145A Lecture 18 - Oncogenes and Cancer Topics we will cover today.
CDC42 a low molecular weight GTP-binding protein originally designated G(p) and also called G25K Chromosomal location: 1p36.1 The CDC42 protein binds to.
Colon cancer is the second leading cause of cancer deaths in the U.S. Polyps, the first stage In tumor development
Neurofibromatosis By Katelynn Johnson and Katie Duvall.
Intramedullary Spinal Cord Lesions in NF1 and NF2
Mouse Models of Human Brain Tumors: From Cage to Clinic David H. Gutmann, MD, PhD Donald O. Schnuck Family Professor Department of Neurology Washington.
Malignant Melanoma and CDKN2A
Β-Catenin, Cancer, and G Proteins Not Just for Frizzleds Anymore Ming Yang et al. PNAS Maria Domenica Castellone et al. Science
BRCA1: Tumor Suppression and Breast Cancer A breast cancer cell dividing.
Problem 1 James is the only person in his kindred affected by DMD. He has one unaffected brother, Joe. DNA analysis show that James has a deletion in the.
P57, Tumorigenesis, and Beckwith-Wiedemann Syndrome Ashley Albright.
NF2/Merlin: THE MAGIC OF MERLIN
Smad4 in Colon & Pancreatic Cancers
Genetics of Cancer Genetic Mutations that Lead to Uncontrolled Cell Growth.
Essentials of Biology Sylvia S. Mader
BMP Receptor 1A Juvenile Polyposis Dayna Neo 3/21/13 Biol
BMPR1A Bone Morphogenetic Protein Receptor 1 A (Juvenile Polyposis & Colon Cancer) Hallie Wieters.
FERM domain proteins and their involvement in metastasis Merlin and ERM proteins: unappreciated roles in cancer development? A McClatchey Nat Rev Cancer.
Benign Versus Malignant Tumors
VIII. CANCER = Uncontrolled Cell Division. Celebs with Cancer.
CHAPTER 19 THE ORGANIZATION AND CONTROL OF EUKARYOTIC GENOMES Copyright © 2002 Pearson Education, Inc., publishing as Benjamin Cummings Section D: The.
Gene Sleuthing Lorraine Sartori Majid Masso Paul R. McCreary.
Regulation of gene expression by mutant and
DEMI DABOR-ALLOH TGF-β Receptor II and Gastric Cancer.
Genetics of Cancer Genetic Mutations that Lead to Uncontrolled Cell Growth.
TSC1 and Facial Angiofibromas
NF1 (Neurofibromatosis Type 1) Greg Hogan Ribbon Representation of NF1-333 Scheffzek, et al. (The EMBO Journal Vol. 17,pp , 1998) Structural.
Types of Genes Associated with Cancer
TSC1/Hamartin and Facial Angiofibromas Biology 169 Ann Hau.
PTEN (Cowden Syndrome) /.../ sld083.htm.
Merlin, tumor suppressor 박건수 Cancer Genetics.
Cancer. Cancer is a disease of the cell cycle Caused by one or more of the following: Increase in growth signals Loss of inhibitory signals In addition,
Cowden’s Disease and PTEN. Cowden’s Disease (CD)  A rare autosomal dominant disease similar to Lehrmitte-Duclos Disease (LDD) and Bannayan-Zonana Syndrome.
Integrin-EGFR Cross-Activation Elizabeth Brooks Department of Chemical Engineering University of Massachusetts, Amherst Peyton Lab Group Meeting December.
Orkhon Tsogtbaatar, ID: April 18, 2012
Colon cancer: the second leading cause of cancer deaths in the U.S. Polyps, the first stage In tumor development
Julie Grondin March 10th, 2005 Bio 169
Kate Bradford BIOL 445 March 5, 2009
Mouse Double Minute 2 (MDM2)
Peyton Rous discovered a virus that causes cancer in chickens
NF2/Merlin Michael Anderson.
Clinical Genetics Lecture 4.
p57 & Beckwith-Weidemann Syndrome
TSC1 in Facial Angiofibromas
Chapter 17: Regulation of cell number
PTEN (a.k.a. MMAC1 and TEP1) and Cowden’s Disease
Graduate School of Medical Science & Egineering
The Role of Patch in Basal Cell Carcinoma
Nat. Rev. Clin. Oncol. doi: /nrclinonc
Figure 1 A schematic representation of the HER2 signalling pathway
Bottom: Diagram of Merlin domains
PTEN Tumor Suppressor and Cancer
BMP Receptor 1a and Juvenile Polyposis Syndrome
Yan Feng, MD, Praveena S. Thiagarajan, PhD, Patrick C. Ma, MD 
Canonical gliomagenesis mediators EGFR, P53, and retinoblastoma protein (RB1) are important for cancer signaling. Canonical gliomagenesis mediators EGFR,
Neoplasia lecture 7 Dr Heyam Awad FRCPath.
Presentation transcript:

NF2 = gene Merlin = protein…a.k.a. schwannomin Tumor Suppressor Tumor suppressive ability comes from partial inhibition of Ras/Rac signaling (phosphorylates in the presence of Ras/Rac).

Similar to ERM family of proteins : membrane-cytoskeleton linking proteins Strong evidence of a role in cell motility and proliferation Sun, et. al. Protein 4.1 tumor suppressors: getting a FERM grip on growth regulation. Journal of Cell Science 2002: 115,

Is considered functionally active in “closed” state – N- (FERM domain) and COOH-terminals self-associate. Serine phosphorylation at COOH-terminus prevents self-association, Merlin is in “open state” and therefore functionally inactive. Sun, et. al. Protein 4.1 tumor suppressors: getting a FERM grip on growth regulation. Journal of Cell Science 2002: 115,

Helps regulate signaling in RhoGTPases (Rho, Rac, and Cdc42). These factors control cell motility and matrix adhesions. Sun, et. al. Protein 4.1 tumor suppressors: getting a FERM grip on growth regulation. Journal of Cell Science 2002: 115,

Neurofibromatosis type II is autosomal dominant Follows Knudson’s “two-hit” hypothesis: – One allelic mutation from parent – One somatic allelic mutation

Loss of function also observed in sporadic tumors (i.e. non- neurofibromatosis type II patients). Proposed model of tumor suppressive function involves phosphorylation of Merlin by kinase cascade initiated through Rho/Rac

Sun, et. al. Protein 4.1 tumor suppressors: getting a FERM grip on growth regulation. Journal of Cell Science 2002: 115,

Increased cell growth/survival/motility! Sun, et. al. Protein 4.1 tumor suppressors: getting a FERM grip on growth regulation. Journal of Cell Science 2002: 115,

Mouse models that are doubly deficient of NF2 (genotype NF2-/-) exhibit lethality in the embryonic stage (days 6.5-7: high specificity). Wild-typeHomozygous mutant McClatchey, et al. The Nf2 tumor suppressor gene product is essential for extraembryonic development immediately prior to gastrulation. Genes & Dev :

Mouse models with one mutated allele of NF2 (genotype NF2+/-) exhibit extensive, multi-systemic tumors with a high rate of metastasis.

Tissue deficient of Merlin loses ability to form cadherin mediated cell-cell junctions. Cells expressing aberrant Ras exhibit contact inhibition. This property can be “rescued” by the addition of wild-type Merlin. McClatchey, Merlin and ERM proteins: unappreciated roles in cancer development? Nature Reviews Cancer Nov

Bilateral Vestibular Schwannoma (Acoustic neuroma) Xiao, et. al. Chinese Medical Journal, 2007, Vol. 120 No. 16 : Chinese Medical Journal, 2007, Vol. 120 No. 16 Classic manifestation = MISME: Multiple Inherited Schwannomas, Meningiomas, Ependymomas Meningioma Tuburculum Sella Meningioma:

Spinal ependymoma – intradural-extramedullary Mesothelioma Ependymoma of the Lumbar Spine: History: Cough:

Observation if tumors diagnosed early Cochlear implants to compensate for hearing loss (vestibular schwannomas) Surgical resection or decompression Stereotactic radiosurgery

Clinical trial for vatalanib in progress at Northwestern University: -patient must be an adult -works as a protein tyrosine kinase inhibitor targeting tumor angiogenesis – nonspecific to NF2/Merlin Precise pathway and interaction with other signaling cascades remains unclear.